| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Timber Pharmaceuticals, Inc. | Director | Common Stock, par value $0.001 per share | 6,100 | $9,937 | $1.63 | 15 Apr 2023 | Direct |
| Timber Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 4,100 | 15 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000143774923010521-gaal-lubor-2023-04-15 | Timber Pharmaceuticals, Inc. | 15 Apr 2023 | 2 | $0 | 4 | Director | 18 Apr 2023, 11:41 |
| /report/000110465922047211-gaal-lubor-2022-04-15 | Timber Pharmaceuticals, Inc. | 15 Apr 2022 | 2 | $0 | 4 | Director | 19 Apr 2022, 12:54 |
| /report/000110465921089395-gaal-lubor-2021-07-01 | Timber Pharmaceuticals, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 06 Jul 2021, 16:06 |